Literature DB >> 18470900

Tumor progression of culture-adapted human embryonic stem cells during long-term culture.

Sheng Yang1, Ge Lin, Yue-Qiu Tan, Di Zhou, Lei-Yu Deng, De-Hua Cheng, Shu-Wei Luo, Tian-Cheng Liu, Xiao-Ying Zhou, Zheng Sun, Yang Xiang, Tian-Ji Chen, Ji-Fang Wen, Guang-Xiu Lu.   

Abstract

Human embryonic stem cells (hESCs) during long-term culture acquire chromosomal changes similar to those occurring in tumorigenesis. This was raised concerns about the progression from hESCs to malignant cells. This study aimed to investigate the changes in chromosomes, cell phenotype, and genes in culture-adapted hESCs to ascertain whether tumorigenic transformation occurred. By cytogenetic analysis we found progressive karyotypic changes from simple to complex in chHES-3, one of the hESC lines established in our laboratory, during a long-term suboptimal culture. We further compared chHES-3 cells at different karyotypic stages in cell surface markers, in vivo differentiation, cell cycle, apoptosis, and gene expression profiles. We found that the karyotypically aberrant chHES-3 had higher S-phase fraction in cell cycle distributions and antiapoptosis ability. In vivo differentiation of karyotypically normal chHES-3 resulted in relatively mature teratoma, whereas karyotypically aberrant chHES-3 formed immature teratoma (grade III), in which more primary neural epithelium was revealed by pathological analysis. The microarray analysis and real-time PCR results showed that some oncogenes were upregulated in karyotypically aberrant chHES-3 cells, whereas the genes related to differentiation were downregulated, and that Wnt signal pathway was activated. In conclusion, chHES-3 cells underwent deregulation of self-renewal and dysfunction of related genes in long-term culture adaptation, leading to malignant transformation. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18470900     DOI: 10.1002/gcc.20574

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  28 in total

1.  Tumourigenic characteristics of embryonal carcinoma cells as a model for studying tumour progression of human embryonic stem cells.

Authors:  S Yang; G Lin; L Deng; G-X Lu
Journal:  Cell Prolif       Date:  2012-08       Impact factor: 6.831

2.  Differences between karyotypically normal and abnormal human embryonic stem cells.

Authors:  S Yang; G Lin; Y-Q Tan; L-Y Deng; D Yuan; G-X Lu
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

Review 3.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

Review 4.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

Review 5.  Genetic and epigenetic stability of human pluripotent stem cells.

Authors:  Riikka J Lund; Elisa Närvä; Riitta Lahesmaa
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

6.  High resolution array-CGH characterization of human stem cells using a stem cell focused microarray.

Authors:  Aaron M Elliott; Kristi A Hohenstein Elliott; Anja Kammesheidt
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

7.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

Review 8.  Genomic instability in pluripotent stem cells: implications for clinical applications.

Authors:  Suzanne E Peterson; Jeanne F Loring
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

9.  Characterization of human embryonic stem cells with features of neoplastic progression.

Authors:  Tamra E Werbowetski-Ogilvie; Marc Bossé; Morag Stewart; Angelique Schnerch; Veronica Ramos-Mejia; Anne Rouleau; Tracy Wynder; Mary-Jo Smith; Steve Dingwall; Tim Carter; Christopher Williams; Charles Harris; Joanna Dolling; Christopher Wynder; Doug Boreham; Mickie Bhatia
Journal:  Nat Biotechnol       Date:  2009-01-04       Impact factor: 54.908

10.  CD30 expression reveals that culture adaptation of human embryonic stem cells can occur through differing routes.

Authors:  Neil J Harrison; James Barnes; Mark Jones; Duncan Baker; Paul J Gokhale; Peter W Andrews
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.